Evidence map›Paper›PMID 41886077›Full record

ArticleInnere Medizin (Heidelberg, Germany)2026

[Severe pulmonary Mycobacterium genavense infection in an immunocompetent adult : Diagnostic challenges and successful macrolide-based combination therapy].

Jonas Früh, Johanna Bolay, Raphaela Kalus, Loraine Früh, Simone Reu-Hofer, Andreas Müller

Abstract readCase ReportsEnglish Abstract
PubMed Publisher
In one paragraph

Article in Innere Medizin (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jonas FrühMedizinische Klinik - Schwerpunkt Pneumologie & Beatmungsmedizin, Standort Missioklinik, Klinikum Würzburg Mitte, Salvatorstr. 7, 97074, Würzburg, Deutschland. Jonas.frueh@kwm-klinikum.de.
Johanna BolayMedizinische Klinik - Schwerpunkt Pneumologie & Beatmungsmedizin, Standort Missioklinik, Klinikum Würzburg Mitte, Salvatorstr. 7, 97074, Würzburg, Deutschland.
Raphaela KalusMedizinische Klinik - Schwerpunkt Pneumologie & Beatmungsmedizin, Standort Missioklinik, Klinikum Würzburg Mitte, Salvatorstr. 7, 97074, Würzburg, Deutschland.
Loraine FrühMedizinische Klinik II, Infektiologie, Universitätsklinikum Würzburg, Würzburg, Deutschland.
Simone Reu-HoferPathologisches Institut, Universität Würzburg, Würzburg, Deutschland.
Andreas MüllerMedizinische Klinik II, Infektiologie, Universitätsklinikum Würzburg, Würzburg, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacterium genavense is a rare cause of non-tuberculous mycobacterial disease, typically occurring in immunocompromised hosts. The case of a 49-year-old immunocompetent man with respiratory symptoms is presented. Imaging revealed a hilar mass with mediastinal lymphadenopathy, initially suggesting malignancy. Molecular diagnostics identified M. genavense as the causative pathogen. A 15-month regimen of rifampicin, azithromycin, and ethambutol led to complete clinical and radiological remission.

Indexed as

Anti-Bacterial AgentsImmunocompetenceMacrolidesMycobacterium Infections, NontuberculousNontuberculous MycobacteriaAntitubercular AgentsAzithromycinDiagnosis, DifferentialDrug Therapy, CombinationEthambutolHumansMaleMiddle AgedRifampinTomography, X-Ray ComputedAnti-Bacterial AgentsAntitubercular AgentsAzithromycinEthambutolMacrolidesRifampinMediastinal lymphadenopathyMolecular pathogen detectionMycobacteriosisNecrotizing granulomasNontuberculous mycobacteria

Identifiers

PMID41886077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.